Instead of a combination of tumor cell ligands or stress signals that coengage innate NK receptors [15], NK cells responding to iRBC were activated by IgG, which is sufficient to trigger CD16 and induce degranulation to release lytic effector molecules [16]. Here, FCGR3A is linked to neoplasm.